Research location
Guiyang
Guizhou, China
Advertisement
Research activity in Guiyang
Guizhou, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 102 trials and 115 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Guiyang
102 linked trials · page 1 of 3Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding StudyNCT07739485 · 2026-07-30 · 1 site observation
RECRUITING
Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding StudyNCT07739511 · 2026-07-29 · 1 site observation
RECRUITING
A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.NCT07593027 · 2026-04-30 · 1 site observation
RECRUITING
Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07464587 · 2026-04-14 · 1 site observation
RECRUITING
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)NCT07416474 · 2026-04-03 · 1 site observation
RECRUITING
HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure ManagementNCT07402239 · 2026-03-16 · 1 site observation
RECRUITING
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionNCT07063745 · 2026-01-02 · 1 site observation
RECRUITING
Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastasesNCT07469267 · 2025-10-24 · 1 site observation
RECRUITING
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) AmyloidosisNCT07207811 · 2025-10-02 · 1 site observation
RECRUITING
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT07043725 · 2025-09-15 · 2 site observations
RECRUITING
Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast CancerNCT07095023 · 2025-08-15 · 1 site observation
RECRUITING
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerNCT07047365 · 2025-07-25 · 2 site observations
RECRUITING
Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast CancerNCT07008976 · 2025-07-07 · 1 site observation
RECRUITING
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT07010263 · 2025-06-13 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514 · 2025-02-27 · 1 site observation
RECRUITING
Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast CancerNCT06889688 · 2025-02-21 · 1 site observation
RECRUITING
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 2 site observations
RECRUITING
A Phase 2 Clinical Study of ABSK061 and ABSK043NCT06632262 · 2024-11-13 · 2 site observations
RECRUITING
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)NCT04974138 · 2024-08-22 · 1 site observation
RECRUITING
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT GenotypeNCT04974151 · 2024-08-22 · 1 site observation
RECRUITING
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy FailureNCT06300177 · 2024-03-28 · 1 site observation
RECRUITING
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung CancerNCT06121505 · 2024-03-01 · 1 site observation
RECRUITING
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC PatientsNCT06155084 · 2023-12-26 · 1 site observation
RECRUITING
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast CancerNCT05744687 · 2023-04-24 · 1 site observation
RECRUITING
FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating HypertensionNCT05590871 · 2023-03-31 · 1 site observation
RECRUITING
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT04928846 · 2022-03-25 · 1 site observation
RECRUITING
Radiotherapy or Observation of Liver Metastases in Small Cell Lung CancerNCT05150145 · 2021-04-30 · 1 site observation
RECRUITING
Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving SurgeryNCT04025164 · 2018-07-01 · 1 site observation
RECRUITING
China Health Big DataNCT03699228 · 2017-12-01 · 1 site observation
RECRUITING
The Chinese Familial Alzheimer's NetworkNCT03657732 · 2005-01-10 · 1 site observation
RECRUITING
China Cognition and Aging StudyNCT03653156 · 2000-01-01 · 1 site observation
RECRUITING
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)NCT07680790 · 2026-09-30 · 1 site observation
NOT_YET_RECRUITING
Effect of Central Venous Catheterization on Brain Pressure in Acute Brain Injury PatientsNCT07704528 · 2026-03-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPDNCT07425210 · 2026-03-01 · 1 site observation
NOT_YET_RECRUITING
DIEP-MDS for Risk Stratification of Flap Vascular Compromise and Failure in Breast ReconstructionNCT07761390 · 2026-01-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood TestsNCT07087041 · 2025-07-15 · 1 site observation
NOT_YET_RECRUITING
Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast CancerNCT06851442 · 2025-05-16 · 2 site observations
TERMINATED
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).NCT06606509 · 2024-11-07 · 1 site observation
NOT_YET_RECRUITING
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLCNCT06709274 · 2024-11-01 · 1 site observation
NOT_YET_RECRUITING
A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast CancerNCT06561607 · 2024-10-11 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisNCT06068465 · 2024-09-27 · 1 site observation
COMPLETED
Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.NCT07335952 · 2024-09-02 · 1 site observation
COMPLETED
A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerNCT06198751 · 2024-02-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Prophylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical StudyNCT06014450 · 2023-09-01 · 1 site observation
UNKNOWN
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.NCT05922345 · 2023-06-08 · 1 site observation
UNKNOWN
YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsNCT05767892 · 2023-05-01 · 1 site observation
NOT_YET_RECRUITING
Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart FailureNCT05586048 · 2023-04-01 · 2 site observations
UNKNOWN
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney DiseaseNCT05593575 · 2023-03-22 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.